Journal of Medicinal Chemistry
Brief Article
amino acids, pseudo-peptide bonds, and cyclization. Curr. Pharm. Des.
2010, 16, 3185−3203.
peripherally administered novel endomorphin-1 analogue containing
β-proline. Eur. J. Pharmacol. 2003, 469, 89−95.
́ ́
(27) Tomboly, C.; Peter, A.; Toth, G. In vitro quantitative study of
(8) Keresztes, A.; Borics, A.; To
th, G. Recent advances in
̈
̈
the degradation of endomorphins. Peptides 2002, 23, 1573−1580.
(28) Liu, H.-M.; Liu, X.-F.; Yao, J.-L; Wang, C.-L.; Yu, Ye; Wang, R.
Utilization of combined chemical modifications to enhance the
blood−brain barrier permeability and pharmacological activity of
endomorphin-1. J. Pharm. Exp. Ther. 2006, 319, 308−316.
(29) Kleczkowska, P.; Bojnik, E.; Lesniak, A.; Kosson, P.; Van den
Eynde, I.; Ballet, S.; Benyhe, S.; Tourwe, D.; Lipkowski, A. W.
Identification of Dmt-D-Lys-Phe-Phe-OH as a highly antinociceptive
tetrapeptide metabolite of the opioid-neurotensin hybrid peptide
PK20. Pharm. Rep. 2013, 65, 836−846.
(30) Yamamoto, T.; Nair, P.; Mab, S.-w.; Davis, P.; Yamamura, H. I.;
Vanderah, T. W.; Porreca, F.; Lai, J.; Hruby, V. J. The biological
activity and metabolic stability of peptidic bifunctional compounds
that are opioid receptor agonists and neurokinin-1 receptor
antagonists with a cystine moiety. Bioorg. Med. Chem. 2009, 17,
7337−7343.
(31) OSIRIS Property Explorer; Organic Chemistry Portal, 2014;
(32) Clark, D. E. In silico prediction of blood−brain barrier
permeation. Drug Discovery Today 2003, 8, 927−933.
(33) Ertl, P.; Rohde, B.; Selzer, P. Fast calculation of molecular polar
surface area as a sum of fragment based contributions and its
application to the prediction of drug transport properties. J. Med.
Chem. 2000, 43, 3714−3717.
(34) Price, D. A.; Blagg, J.; Jones, L.; Greene, N.; Wager, T.
Physicochemical drug properties associated with in vivo toxicological
outcomes: a review. Expert Opin. Drug Metab. Toxicol. 2009, 5, 921−
931.
endomorphin engineering. ChemMedChem 2010, 5, 1176−1196.
(9) Gentilucci, L. New trends in the development of opioid peptide
analogues as advanced remedies for pain relief. Curr. Top. Med. Chem.
2004, 4, 19−38.
(10) Liu, W. L.; Wang, R. Endomorphins: potential roles and
therapeutic indications in the development of opioid peptide analgesic
drugs. Med. Res. Rev. 2012, 32, 536−580.
(11) Cardillo, G.; Gentilucci, L.; Tolomelli, A.; Spinosa, R.; Calienni,
M.; Qasem, A. R.; Spampinato, S. Synthesis and evaluation of the
affinity toward μ-opioid receptors of atypical, lipophilic ligands based
on the sequence c[Tyr-Pro-Trp-Phe-Gly]. J. Med. Chem. 2004, 47,
5198−5203.
(12) Gentilucci, L.; Tolomelli, A.; De Marco, R.; Artali, R. Molecular
docking of opiates and opioid peptides, a tool for the design of
selective agonists and antagonists, and for the investigation of atypical
ligand-receptor interactions. Curr. Med. Chem. 2012, 19, 1587−1601.
(13) Bedini, A.; Baiula, M.; Gentilucci, L.; Tolomelli, A.; De Marco,
R.; Spampinato, S. Peripheral antinociceptive effects of the cyclic
endomorphin-1 analog c[YpwFG] in a mouse visceral pain model.
Peptides 2010, 31, 2135−2140.
(14) Gentilucci, L.; Tolomelli, A.; De Marco, R.; Spampinato, S.;
Bedini, A.; Artali, R. The inverse type II beta-turn on D-Trp-Phe, a
pharmacophoric motif for MOR agonists. ChemMedChem 2011, 6,
1640−1653.
(15) De Marco, R.; Tolomelli, A.; Spampinato, S.; Bedini, A.;
Gentilucci, L. Opioid activity profiles of oversimplified peptides lacking
in the protonable N-terminus. J. Med. Chem. 2012, 55, 10292−10296.
(16) Aldrich, J. V.; Kulkarni, S. S.; Senadheera, S. N.; Ross, N. C.;
Reilley, K. J.; Eans, S. O.; Ganno, M. L.; Murray, T. F.; McLaughlin, J.
P. Unexpected opioid activity profiles of analogues of the novel
peptide κ-opioid receptor ligand CJ-15,208. ChemMedChem 2011, 6,
1739−1745.
(35) Di, L.; Rong, H.; Feng, B. Demystifying brain penetration in
central nervous system drug discovery. J. Med. Chem. 2013, 56, 2−12.
(36) Leeson, P. D.; Springthorpe, B. The influence of drug-like
concepts on decision-making in medicinal chemistry. Nature Rev. Drug
Discovery 2007, 6, 881−890.
(17) Gentilucci, L.; Cerisoli, L.; De Marco, R.; Tolomelli, A. A simple
route towards peptide analogues containing substituted (S)- or (R)-
tryptophans. Tetrahedron Lett. 2010, 51, 2576−2579.
(18) Kieffer, M. E.; Repka, L. M.; Reisman, S. E. Enantioselective
synthesis of tryptophan derivatives by a tandem Friedel−Crafts
conjugate addition/asymmetric protonation reaction. J. Am. Chem. Soc.
2012, 134, 5131−5137.
(19) Konda-Yamada, Y.; Okada, C.; Yoshida, K.; Umeda, Y.; Arima,
S.; Sato, N.; Kai, T.; Takayanagi, H.; Harigaya, Y. Convenient synthesis
of 7′ and 6′-bromo-D-tryptophan and their derivatives by enzymatic
optical resolution using D-aminoacylase. Tetrahedron 2002, 58, 7851−
7861.
(37) Tarcsay, A.; Nyíri, K.; Keseru, G. M. Impact of lipophilic
̋
efficiency on compound quality. J. Med. Chem. 2012, 55, 1252−1260.
(38) Kastin, A. J.; Fasold, M. B.; Smith, R. R.; Horner, K. A.; Zadina,
J. E. Saturable brain-to-blood transport of endomorphins. Exp. Brain.
Res. 2001, 139, 70−75.
(39) Smith, D. A.; Di, L.; Kerns, E. H. The effect of plasma protein
binding on in vivo efficacy: misconceptions in drug discovery. Nature
Rev. Drug Discovery 2010, 9, 929−939.
(40) Ung, P.; Winkler, D. A. Tripeptide motifs in biology: targets for
peptidomimetic design. J. Med. Chem. 2011, 54, 1111−1125.
(20) Blaser, G.; Sanderson, J. M.; Batsanov, A. S.; Howard, J. A. K.
The facile synthesis of a series of tryptophan derivatives. Tetrahedron
Lett. 2008, 49, 2795−2798.
(21) Acylase I from Porcine Kidney; Sigma-Aldrich, 2014; www.
(22) Sim, L. J.; Liu, Q.; Childers, S. R.; Selley, D. E. Endomorphin
stimulated [35S]GTPγS binding in rat brain: evidence for partial
agonist activity at μ-opioid receptors. J. Neurochem. 1998, 70, 1567−
1576.
(23) Ron
Orosz, G.; Tot
́
ai, A. Z.; Al-Khrasani, M.; Benyhe, S.; Lengyel, I.; Kocsis, L.;
́
h, G.; Kato, E.; Tothfalusi, L. Partial and full agonism in
́
́
endomorphin derivatives: comparison by null and operational models.
Peptides 2006, 27, 1507−1513.
(24) Gentry, C. L.; Egleton, R. D.; Gillespie, T.; Abbruscato, T. J.;
Bechowski, H. B.; Hruby, V. J.; Davis, T. P. The effect of halogenation
on blood−brain barrier permeability of a novel peptide drug. Peptides
1999, 20, 1229−1238.
(25) Janecka, A.; Staniszewska, R.; Gach, K.; Fichna, J. Enzymatic
degradation of endomorphins. Peptides 2008, 29, 2066−2073.
(26) Spampinato, S.; Qasem, A. R.; Calienni, M.; Murari, G.;
Gentilucci, L.; Tolomelli, A.; Cardillo, G. Antinociception by a
F
dx.doi.org/10.1021/jm5002925 | J. Med. Chem. XXXX, XXX, XXX−XXX